Prosecution Insights
Prosecution Insights
33 pending office actions • 25 clients • 32 examiners • 25 art units • 0 of 33 (0%) have an AI response strategy ready • 42 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 19 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 19 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §103 only | 19 (58%) |
| §102 only | 2 (6%) |
| §112 only | 3 (9%) |
| Double-patenting only | 4 (12%) |
| Double-patenting + other | 1 (3%) |
| No statute on record | 3 (9%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SU-TOBON, QIWEN NMN | 2 | 66.7% | +100.0% |
| WEHBE, ANNE MARIE SABRINA | 1 | 57.4% | +42.6% |
| HAILEY, PATRICIA L | 1 | 88.1% | +10.2% |
| GOLDBERG, JEANINE ANNE | 1 | 45.9% | +40.8% |
| TURPIN, ZACHARY MARK | 1 | 0.0% | +0.0% |
| SCHLIENTZ, NATHAN W | 1 | 41.2% | -19.1% |
| CARTER, SANDRA DILLAHUNT | 1 | 55.9% | +29.9% |
| DAVIS, RUTH A | 1 | 60.8% | +31.2% |
| YU, TIAN NMN | 1 | 56.1% | +13.6% |
| SHAHNAN SHAH, KHATOL S | 1 | 62.6% | +53.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18692624 | PHOTOCATALYTIC AEROBIC OXIDATION OF YPERITE OR AN ANALOG THEREOF | HAILEY, PATRICIA L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18564121 | RNA APTAMERS SPECIFIC FOR A-SYNUCLEIN PROTEIN FIBER CONFORMERS | YU, TIAN NMN | 82d |
| 18556185 | PRIMER SET, REAGENT COMPOSITION AND METHOD FOR THE DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) | TURPIN, ZACHARY MARK | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18557471 | COMBINATION PRODUCT AND METHODS FOR PREVENTING THE EMERGENCE OF ANTIBIOTIC-RESISTANT BACTERIA UNDER ANTIBIOTIC TREATMENT | SHAHNAN SHAH, KHATOL S | 97d overdue |
| 18546024 | METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY | SU-TOBON, QIWEN NMN | 27d |
| 18253977 | USE OF AMINOQUINOLINE COMPOUNDS FOR HIGHER GENE INTEGRATION | SU-TOBON, QIWEN NMN | 63d |
| 18564121 | RNA APTAMERS SPECIFIC FOR A-SYNUCLEIN PROTEIN FIBER CONFORMERS | YU, TIAN NMN | 82d |
| 18744060 | Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Cancer in a HLA-A*0201-Positive Patient Having a Non-Immunogenic Tumor Expressing Tert | WEHBE, ANNE MARIE SABRINA | — |
| 18692624 | PHOTOCATALYTIC AEROBIC OXIDATION OF YPERITE OR AN ANALOG THEREOF | HAILEY, PATRICIA L | — |
| 18577040 | PRIMER SET, REAGENT COMPOSITION AND METHOD FOR THE DETECTION OF NEISSERIA MENINGITIDIS | GOLDBERG, JEANINE ANNE | — |
| 18532790 | DIPEPTIDYLPEPTIDASE 4 INHIBITION ENHANCES LYMPHOCYTE TRAFFICKING, IMPROVING BOTH NATURALLY OCCURRING TUMOR IMMUNITY AND IMMUNOTHERAPY | CARTER, SANDRA DILLAHUNT | — |
| Art Unit | Apps |
|---|---|
| 1682 | 3 |
| 1671 | 2 |
| 1636 | 2 |
| 1632 | 2 |
| 1616 | 1 |
| 1699 | 1 |
| 1681 | 1 |
| 1645 | 1 |
| 1647 | 1 |
| 3991 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18744060 | Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Cancer in a HLA-A*0201-Positive Patient Having a Non-Immunogenic Tumor Expressing Tert | Kriptic Pharmaceuticals Limited | WEHBE, ANNE MARIE SABRINA | DP | Non-Final OA | — | Pending | Jun 14, 2024 | |
| 18692624 | PHOTOCATALYTIC AEROBIC OXIDATION OF YPERITE OR AN ANALOG THEREOF | COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES | HAILEY, PATRICIA L | §102 | Non-Final OA | — | Pending | Mar 15, 2024 | |
| 18577040 | PRIMER SET, REAGENT COMPOSITION AND METHOD FOR THE DETECTION OF NEISSERIA MENINGITIDIS | Genomtec S.A. | GOLDBERG, JEANINE ANNE | 1682 | §103 | Final Rejection | — | Pending | Jan 05, 2024 |
| 18556185 | PRIMER SET, REAGENT COMPOSITION AND METHOD FOR THE DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) | Genomtec S.A. | TURPIN, ZACHARY MARK | 1682 | §103 | Non-Final OA | — | Pending | Dec 27, 2023 |
| 18571952 | COMPOSITION COMPRISING POTASSIUM BICARBONATE AND USE THEREOF FOR TREATING AND/OR PROTECTING CROPS | Scea Du Chateau Montrose | SCHLIENTZ, NATHAN W | 1616 | §103 | Final Rejection | — | Pending | Dec 19, 2023 |
| 18532790 | DIPEPTIDYLPEPTIDASE 4 INHIBITION ENHANCES LYMPHOCYTE TRAFFICKING, IMPROVING BOTH NATURALLY OCCURRING TUMOR IMMUNITY AND IMMUNOTHERAPY | INSERM | CARTER, SANDRA DILLAHUNT | DP | Non-Final OA | — | Pending | Dec 07, 2023 | |
| 18566310 | ASSOCIATION OF A VEGETAL ACTIVE EXTRACT CONTAINING SUPEROXIDE DISMUTASE (SOD) AND A FENUGREEK EXTRACT AND USES THEREOF | Robertet SA | DAVIS, RUTH A | 1699 | §103 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18564121 | RNA APTAMERS SPECIFIC FOR A-SYNUCLEIN PROTEIN FIBER CONFORMERS | Centre National De La Recherche Scientifique (Cnrs) | YU, TIAN NMN | 1681 | §101 | Non-Final OA | 82d | Pending | Nov 27, 2023 |
| 18557471 | COMBINATION PRODUCT AND METHODS FOR PREVENTING THE EMERGENCE OF ANTIBIOTIC-RESISTANT BACTERIA UNDER ANTIBIOTIC TREATMENT | Assistance Publique - Hôpitaux de Paris | SHAHNAN SHAH, KHATOL S | 1645 | §103 | Non-Final OA | 97d overdue | Pending | Oct 26, 2023 |
| 18288115 | HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF | Institut Pasteur | BARRERA, IMMACULADA | 1671 | §103 | Non-Final OA | — | Pending | Oct 24, 2023 |
| 18547274 | AN ARTIFICIAL PROTEIN-CAGE DECORATED WITH PARTICULAR MOLECULES ON THE EXTERIOR | UNIWERSYTET JAGIELLONSKI | BUTTICE, AUDREY L | 1647 | DP | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18547471 | ANTIBODIES, FRAGMENTS OR DERIVATIVES SPECIFICALLY BINDING TO A PROTEIN ANTIGEN CAPABLE OF BINDING TO NUCLEIC ACIDS AND USES OF SAME | COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES | DRISCOLL, LORA E BARNHART | 3991 | §112 | Final Rejection | 25d overdue | Pending | Aug 22, 2023 |
| 18236260 | COMPOSITION COMPRISING FLAVIN ADENINE DINUCLEOTIDE (FAD), L-GSH, ATP AND MYRISTIC ACID, ALONE OR WITH A DRUG | BIO EVEN | SHIAO, YIH-HORNG | 1691 | §103 | Non-Final OA | 56d | Pending | Aug 21, 2023 |
| 18547256 | AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF | UNIWERSYTET JAGIELLONSKI | SWIFT, CANDICE LEE | 1657 | Other | Non-Final OA | 4d overdue | Pending | Aug 21, 2023 |
| 18546024 | METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY | Institut Pasteur | SU-TOBON, QIWEN NMN | 1636 | Other | Non-Final OA | 27d | Pending | Aug 10, 2023 |
| 18264965 | IMMUNOLOGICAL TEST FOR THE DETECTION OF VIRAL INFECTIONS | BIOSPEEDIA | LY, KRISTINA ELISABETH | 1671 | §103 | Non-Final OA | 15d overdue | Pending | Aug 10, 2023 |
| 18259979 | DRUG ELUTING STENT | Sino Medical Sciences Technology Inc. | LYNCH, ROBERT A | 3771 | §102 | Non-Final OA | 71d overdue | Pending | Jun 29, 2023 |
| 18258931 | METHODS AND COMPOSITIONS | Plant Bioscience Limited | PAGUIO FRISING, MICHELLE F | 1651 | DPOther | Non-Final OA | 61d | Pending | Jun 22, 2023 |
| 18257727 | GENE THERAPY FOR TREATING USHER SYNDROME | Assistance Publique-Hopitaux De Paris | THUESON, HANNA MARIE | 1638 | §103 | Non-Final OA | 99d overdue | Pending | Jun 15, 2023 |
| 17997439 | POROUS BONE SUBSTITUTION MATERIAL | Etat Francais Represente Par La Direction Centrale Du Service De Sante Des Armées | BLANCO, JAVIER G | 3774 | §103 | Final Rejection | 4d overdue | Pending | Jun 09, 2023 |
| 18253977 | USE OF AMINOQUINOLINE COMPOUNDS FOR HIGHER GENE INTEGRATION | Cellectis SA | SU-TOBON, QIWEN NMN | 1636 | §103 | Non-Final OA | 63d | Pending | May 23, 2023 |
| 18044008 | ANTI-ARGONAUTE PROTEIN AUTOANTIBODIES AS BIOMARKERS OF AUTOIMMUNE NEUROLOGICAL DISEASES | INSERM | COUNTS, GARY W | 1678 | §103 | Non-Final OA | — | Pending | Mar 03, 2023 |
| 18005284 | T-CELLS EXPRESSING IMMUNE CELL ENGAGERS IN ALLOGENIC SETTINGS | Cellectis S.A. | NICOL, ALEXANDER W | 1634 | §103 | Final Rejection | 26d overdue | Pending | Jan 12, 2023 |
| 18005146 | SARS-COV-2 IMMUNOGENIC COMPOSITIONS, VACCINES, AND METHODS | Theravectys | CHEN, STACY BROWN | 1672 | DP | Non-Final OA | — | Pending | Jan 11, 2023 |
| 18004782 | SYSTEM | Gtinvent Limited | STAVROU, CONSTANTINA E | 1632 | §103 | Final Rejection | 9d | Pending | Jan 09, 2023 |
| 18002814 | INHIBITORS OF ACID SPHINGOMYELINASE FOR PREVENTING AND TREATING THE COVID-19 DISEASE | UNIVERSITE PARIS CITE | WELLS, LAUREN QUINLAN | 1622 | Other | Final Rejection | 14d | Pending | Dec 21, 2022 |
| 17996127 | BACTERIAL STRAINS FOR USE AS PROBIOTICS, COMPOSITIONS THEREOF, DEPOSITED STRAINS AND METHOD TO IDENTIFY PROBIOTIC BACTERIAL STRAINS | Institut Pasteur | ZINGARELLI, SANDRA | 1653 | §103 | Final Rejection | 8d | Pending | Oct 13, 2022 |
| 17742173 | VITRO ISOLATION AND ENRICHMENT OF NUCLEIC ACIDS USING SITE-SPECIFIC NUCLEASES | Depixus | GRAY, JESSICA | 1682 | §103 | Final Rejection | 72d | Pending | May 11, 2022 |
| 17702592 | Use of a Warmer For Promoting a Biological Reaction | Ibsa Pharma SAS | SMALL, KATHERINE R | 1633 | §103 | Non-Final OA | — | Pending | Mar 23, 2022 |
| 17620819 | ANTHRACYCLINE DERIVATIVES | Almac Discovery Limited | HOPKINS, SAMANTHA LAKE | 1641 | §103 | Final Rejection | — | Pending | Dec 20, 2021 |
| 17055061 | SUBSTITUTION OF THE MESSENGER RNA CAP WITH TWO RNA SEQUENCES INTRODUCED AT THE 5-PRIME END THEREOF | Messenger Biopharma | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Final Rejection | 81d overdue | Pending | Nov 12, 2020 |
| 16611172 | Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker Patient | Kriptic Pharmaceuticals Limited | COFFA, SERGIO | 1658 | §112 | Final Rejection | 18d overdue | Pending | Nov 05, 2019 |
| 15713347 | WIDESPREAD GENE DELIVERY TO MOTOR NEURONS USING PERIPHERAL INJECTION OF AAV VECTORS | Centre National De La Recherche Scientifique | SINGH, ANOOP KUMAR | 1632 | §112 | Non-Final OA | — | Pending | Sep 22, 2017 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial